MVK and hyperinsulinemic hypoglycemia, familial, 4: De Benedetti F, A J, Ben-Chetrit E, Calvo I et al (2016) Efficacy and safety of canakinumab in patients with colchicine-resistant familial mediterranean fever, hyper-immunoglobulin d syndrome/mevalonate kinase deficiency and tnf receptor-associated periodic syndrome: 40 week results from the pivotal phase 3 umbrella cluster trial.